Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) Revenue
Veeva Systems Inc.'s revenue for fiscal 2026 was $3.2B, up 16.3% from $2.7B in fiscal 2025. Over the twelve months to 31 July 2026 it was $3.5B. Over the past ten years it has ranged from $313.2M (fiscal 2015) to $3.2B (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 11 consecutive fiscal years. Veeva Systems Inc. ranks 2nd of 48 Health Information Services companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $3.2B | 16.34% |
| FY2025 | $2.7B | 16.20% |
| FY2024 | $2.4B | 9.68% |
| FY2023 | $2.2B | 16.44% |
| FY2022 | $1.9B | 26.33% |
| FY2021 | $1.5B | 32.70% |
| FY2020 | $1.1B | 28.05% |
| FY2019 | $862.2M | 24.86% |
| FY2018 | $690.6M | 25.43% |
| FY2017 | $550.5M | 34.53% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $928.0M | 5.10% |
| Apr 2026 | $882.9M | 5.62% |
| Jan 2026 | $836.0M | 3.05% |
| Oct 2025 | $811.2M | 2.81% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $14.4B |
| VEEV Veeva Systems Inc. | $3.5B |
| TEM Tempus AI, Inc. compare | $1.4B |
| HQY HealthEquity, Inc. compare | $1.4B |
| WAY Waystar Holding Corp. compare | $1.2B |
| HNGE Hinge Health Inc. compare | $720.1M |
| DOCS Doximity, Inc. compare | $655.6M |
| TXG 10x Genomics compare | $616.9M |
| HTFL Heartflow, Inc. compare | $212.1M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on VEEV
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement